Keywords
Last Name
Institution

David A. Thorley-Lawson

TitleProfessor
InstitutionTufts University School of Medicine
DepartmentIntegrative Physiology and Pathobiology
AddressIntegrative Physiology and Pathobiology
Tufts University School of Medicine
136 Harrison Avenue
Boston MA 02111-1800
Phone(617) 636-2726
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Thorley-Lawson D, Deitsch KW, Duca KA, Torgbor C. The Link between Plasmodium falciparum Malaria and Endemic Burkitt's Lymphoma-New Insight into a 50-Year-Old Enigma. PLoS Pathog. 2016 Jan; 12(1):e1005331. PMID: 26794909.
      View in: PubMed
    2. Qiu J, Smith P, Leahy L, Thorley-Lawson DA. The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo. PLoS Pathog. 2015 Jan; 11(1):e1004561. PMID: 25590614.
      View in: PubMed
    3. Thorley-Lawson DA. EBV Persistence-Introducing the Virus. Curr Top Microbiol Immunol. 2015; 390:151-209. PMID: 26424647.
      View in: PubMed
    4. Qiu J, Thorley-Lawson DA. EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci U S A. 2014 Jul 29; 111(30):11157-62. PMID: 25012295; PMCID: PMC4121837 [Available on 01/29/15].
      View in: PubMed
      View in: PubMed Central
    5. Torgbor C, Awuah P, Deitsch K, Kalantari P, Duca KA, Thorley-Lawson DA. A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis. PLoS Pathog. 2014 May; 10(5):e1004170. PMID: 24874410; PMCID: PMC4038605.
      View in: PubMed
      View in: PubMed Central
    6. Hawkins JB, Delgado-Eckert E, Thorley-Lawson DA, Shapiro M. The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation. PLoS Pathog. 2013; 9(10):e1003685. PMID: 24146621; PMCID: PMC3798424.
      View in: PubMed
      View in: PubMed Central
    7. Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013 Jun; 3(3):227-32. PMID: 23683686; NIHMSID: NIHMS481124.
      View in: PubMed
    8. Tracy SI, Kakalacheva K, L├╝nemann JD, Luzuriaga K, Middeldorp J, Thorley-Lawson DA. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol. 2012 Nov; 86(22):12330-40. PMID: 22951828; PMCID: PMC3486485.
      View in: PubMed
      View in: PubMed Central
    9. Hawkins JB, Jones MT, Plassmann PE, Thorley-Lawson DA. Chemotaxis in densely populated tissue determines germinal center anatomy and cell motility: a new paradigm for the development of complex tissues. PLoS One. 2011; 6(12):e27650. PMID: 22145018; PMCID: PMC3228727.
      View in: PubMed
      View in: PubMed Central
    10. Smith PA, Merritt D, Barr L, Thorley-Lawson DA. An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis. Genes Cancer. 2011 Nov; 2(11):1023-33. PMID: 22737268; PMCID: PMC3379566.
      View in: PubMed
      View in: PubMed Central
    11. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 2011 Aug; 7(8):e1002193. PMID: 21901094; PMCID: PMC3161978.
      View in: PubMed
      View in: PubMed Central
    12. Clute SC, Naumov YN, Watkin LB, Aslan N, Sullivan JL, Thorley-Lawson DA, Luzuriaga K, Welsh RM, Puzone R, Celada F, Selin LK. Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol. 2010 Dec 1; 185(11):6753-64. PMID: 21048112; NIHMSID: NIHMS252564.
      View in: PubMed
    13. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, W├╝rdinger T, Middeldorp JM. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A. 2010 Apr 6; 107(14):6328-33. PMID: 20304794; PMCID: PMC2851954.
      View in: PubMed
      View in: PubMed Central
    14. Roughan JE, Torgbor C, Thorley-Lawson DA. Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol. 2010 Jan; 84(2):1158-68. PMID: 19889783; PMCID: PMC2798379.
      View in: PubMed
      View in: PubMed Central
    15. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog. 2009 Jul; 5(7):e1000496. PMID: 19578433; PMCID: PMC2698984.
      View in: PubMed
      View in: PubMed Central
    16. Roughan JE, Thorley-Lawson DA. The intersection of Epstein-Barr virus with the germinal center. J Virol. 2009 Apr; 83(8):3968-76. PMID: 19193789; PMCID: PMC2663245.
      View in: PubMed
      View in: PubMed Central
    17. Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol. 2009 Mar; 83(5):2357-67. PMID: 19091858; PMCID: PMC2643705.
      View in: PubMed
      View in: PubMed Central
    18. Thorley-Lawson DA, Allday MJ. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol. 2008 Dec; 6(12):913-24. PMID: 19008891.
      View in: PubMed
    19. Thorley-Lawson DA, Duca KA, Shapiro M. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality. Trends Immunol. 2008 Apr; 29(4):195-201. PMID: 18328785.
      View in: PubMed
    20. Shapiro M, Duca KA, Lee K, Delgado-Eckert E, Hawkins J, Jarrah AS, Laubenbacher R, Polys NF, Hadinoto V, Thorley-Lawson DA. A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol. 2008 Jun 21; 252(4):633-48. PMID: 18371986; NIHMSID: NIHMS55445.
      View in: PubMed
    21. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood. 2008 Feb 1; 111(3):1420-7. PMID: 17991806; PMCID: PMC2214734.
      View in: PubMed
      View in: PubMed Central
    22. Duca KA, Shapiro M, Delgado-Eckert E, Hadinoto V, Jarrah AS, Laubenbacher R, Lee K, Luzuriaga K, Polys NF, Thorley-Lawson DA. A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog. 2007 Oct 19; 3(10):1388-400. PMID: 17953479; PMCID: PMC2034398.
      View in: PubMed
      View in: PubMed Central
    23. Sun CC, Thorley-Lawson DA. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol. 2007 Dec; 81(24):13566-77. PMID: 17898050; PMCID: PMC2168822.
      View in: PubMed
      View in: PubMed Central
    24. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Influence of EBV on the peripheral blood memory B cell compartment. J Immunol. 2007 Sep 1; 179(5):3153-60. PMID: 17709530.
      View in: PubMed
    25. Thorley-Lawson DA, Duca KA. Pathogens cooperate in lymphomagenesis. Nat Med. 2007 Aug; 13(8):906-7. PMID: 17680002.
      View in: PubMed
    26. Castiglione F, Duca K, Jarrah A, Laubenbacher R, Hochberg D, Thorley-Lawson D. Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics. 2007 Jun 1; 23(11):1371-7. PMID: 17341499.
      View in: PubMed
    27. Pegtel DM, Subramanian A, Meritt D, Tsai CH, Sheen TS, Golub TR, Thorley-Lawson DA. IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res. 2007 Jan 15; 67(2):474-81. PMID: 17234754.
      View in: PubMed
    28. Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18093-8. PMID: 16330748; PMCID: PMC1306799.
      View in: PubMed
      View in: PubMed Central
    29. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol. 2005 Dec; 79(24):15430-42. PMID: 16306614; PMCID: PMC1316046.
      View in: PubMed
      View in: PubMed Central
    30. Thorley-Lawson DA. EBV the prototypical human tumor virus--just how bad is it? J Allergy Clin Immunol. 2005 Aug; 116(2):251-61; quiz 262. PMID: 16083776.
      View in: PubMed
    31. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005 Jun 1; 174(11):6599-607. PMID: 15905498.
      View in: PubMed
    32. Hochberg DR, Thorley-Lawson DA. Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. Methods Mol Biol. 2005; 292:39-56. PMID: 15507700.
      View in: PubMed
    33. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 2005 Jan; 79(2):1296-307. PMID: 15613356; PMCID: PMC538585.
      View in: PubMed
      View in: PubMed Central
    34. Pegtel DM, Middeldorp J, Thorley-Lawson DA. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol. 2004 Nov; 78(22):12613-24. PMID: 15507648; PMCID: PMC525079.
      View in: PubMed
      View in: PubMed Central
    35. Hochberg D, Souza T, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol. 2004 May; 78(10):5194-204. PMID: 15113901; PMCID: PMC400374.
      View in: PubMed
      View in: PubMed Central
    36. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004 Mar 25; 350(13):1328-37. PMID: 15044644.
      View in: PubMed
    37. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A. 2004 Jan 6; 101(1):239-44. PMID: 14688409; PMCID: PMC314169.
      View in: PubMed
      View in: PubMed Central
    38. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity. 2002 May; 16(5):745-54. PMID: 12049725.
      View in: PubMed
    39. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001 Oct; 1(1):75-82. PMID: 11905817.
      View in: PubMed
    40. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 2001 Oct; 15(4):579-89. PMID: 11672540.
      View in: PubMed
    41. Babcock GJ, Miyashita-Lin EM, Thorley-Lawson DA. Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo. Methods Mol Biol. 2001; 174:103-10. PMID: 11357631.
      View in: PubMed
    42. Decker LL, Babcock GJ, Thorley-Lawson DA. Detection and discrimination of latent and replicative herpesvirus infection at the single cell level in vivo. Methods Mol Biol. 2001; 174:111-6. PMID: 11357632.
      View in: PubMed
    43. Joseph AM, Babcock GJ, Thorley-Lawson DA. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. J Virol. 2000 Nov; 74(21):9964-71. PMID: 11024124; PMCID: PMC102034.
      View in: PubMed
      View in: PubMed Central
    44. Babcock GJ, Thorley-Lawson DA. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12250-5. PMID: 11035774; PMCID: PMC17327.
      View in: PubMed
      View in: PubMed Central
    45. Joseph AM, Babcock GJ, Thorley-Lawson DA. EBV persistence involves strict selection of latently infected B cells. J Immunol. 2000 Sep 15; 165(6):2975-81. PMID: 10975805.
      View in: PubMed
    46. Babcock GJ, Decker LL, Freeman RB, Thorley-Lawson DA. Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med. 1999 Aug 16; 190(4):567-76. PMID: 10449527; PMCID: PMC2195601.
      View in: PubMed
      View in: PubMed Central
    47. Thorley-Lawson DA, Babcock GJ. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci. 1999; 65(14):1433-53. PMID: 10530796.
      View in: PubMed
    48. Ianelli CJ, DeLellis R, Thorley-Lawson DA. CD48 binds to heparan sulfate on the surface of epithelial cells. J Biol Chem. 1998 Sep 4; 273(36):23367-75. PMID: 9722571.
      View in: PubMed
    49. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity. 1998 Sep; 9(3):395-404. PMID: 9768759.
      View in: PubMed
    50. Ianelli CJ, Edson CM, Thorley-Lawson DA. A ligand for human CD48 on epithelial cells. J Immunol. 1997 Oct 15; 159(8):3910-20. PMID: 9378979.
      View in: PubMed
    51. Jones MZ, Alroy J, Rutledge JC, Taylor JW, Alvord EC, Toone J, Applegarth D, Hopwood JJ, Skutelsky E, Ianelli C, Thorley-Lawson D, Mitchell-Herpolsheimer C, Arias A, Sharp P, Evans W, Sillence D, Cavanagh KT. Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol. 1997 Oct; 56(10):1158-67. PMID: 9329460.
      View in: PubMed
    52. Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J Biol Chem. 1997 Aug 8; 272(32):19777-84. PMID: 9242637.
      View in: PubMed
    53. Nicholson LJ, Hopwood P, Johannessen I, Salisbury JR, Codd J, Thorley-Lawson D, Crawford DH. Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells. Oncogene. 1997 Jul 17; 15(3):275-83. PMID: 9233762.
      View in: PubMed
    54. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol. 1997 Jul; 71(7):4882-91. PMID: 9188550; PMCID: PMC191718.
      View in: PubMed
      View in: PubMed Central
    55. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med. 1996 Sep 1; 184(3):971-80. PMID: 9064357; PMCID: PMC2192769.
      View in: PubMed
      View in: PubMed Central
    56. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Is EBV persistence in vivo a model for B cell homeostasis? Immunity. 1996 Aug; 5(2):173-9. PMID: 8769480.
      View in: PubMed
    57. Decker LL, Shankar P, Khan G, Freeman RB, Dezube BJ, Lieberman J, Thorley-Lawson DA. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med. 1996 Jul 1; 184(1):283-8. PMID: 8691144; PMCID: PMC2192669.
      View in: PubMed
      View in: PubMed Central
    58. Decker LL, Klaman LD, Thorley-Lawson DA. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J Virol. 1996 May; 70(5):3286-9. PMID: 8627812; PMCID: PMC190195.
      View in: PubMed
      View in: PubMed Central
    59. Thorley-Lawson DA, Miyashita EM, Khan G. Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 1996 May; 4(5):204-8. PMID: 8727601.
      View in: PubMed
    60. Sutkowski N, Thorley-Lawson DA, Huber BT. The interplay of herpesviruses in AIDS: superantigen sharing. Trends Microbiol. 1996 Mar; 4(3):89-91. PMID: 8868084.
      View in: PubMed
    61. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 1995 Feb 24; 80(4):593-601. PMID: 7532548.
      View in: PubMed
    62. Klaman LD, Thorley-Lawson DA. Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site. J Virol. 1995 Feb; 69(2):871-81. PMID: 7815555; PMCID: PMC188654.
      View in: PubMed
      View in: PubMed Central
    63. Miyashita E, Thorley-Lawson DA. A new form of Epstein-Barr virus latency in vivo. Curr Top Microbiol Immunol. 1995; 194:135-44. PMID: 7895488.
      View in: PubMed
    64. Thorley-Lawson DA, Ianelli C, Klaman LD, Staunton D, Yokoyama S. Function of CD48 and its regulation by Epstein-Barr virus. Biochem Soc Trans. 1993 Nov; 21(4):976-80. PMID: 8132103.
      View in: PubMed
    65. Moorthy RK, Thorley-Lawson DA. Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J Virol. 1993 May; 67(5):2637-45. PMID: 8386269; PMCID: PMC237585.
      View in: PubMed
      View in: PubMed Central
    66. Moorthy RK, Thorley-Lawson DA. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol. 1993 Mar; 67(3):1638-46. PMID: 8382313; PMCID: PMC237535.
      View in: PubMed
      View in: PubMed Central
    67. Moorthy R, Thorley-Lawson DA. Mutational analysis of the transforming function of the EBV encoded LMP-1. Curr Top Microbiol Immunol. 1992; 182:359-65. PMID: 1337030.
      View in: PubMed
    68. Klaman LD, Hurley EA, Thorley-Lawson DA. Is there a unique episome in EBV transformed B cells? Virology. 1991 Dec; 185(2):883-7. PMID: 1660206.
      View in: PubMed
    69. Hurley EA, Klaman LD, Agger S, Lawrence JB, Thorley-Lawson DA. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J Virol. 1991 Jul; 65(7):3958-63. PMID: 1645805; PMCID: PMC241437.
      View in: PubMed
      View in: PubMed Central
    70. Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin JJ, Thorley-Lawson DA. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol. 1991 Apr 1; 146(7):2192-200. PMID: 1848579.
      View in: PubMed
    71. Fisher RC, Thorley-Lawson DA. Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48). Mol Cell Biol. 1991 Mar; 11(3):1614-23. PMID: 1847502; PMCID: PMC369456.
      View in: PubMed
      View in: PubMed Central
    72. Hurley EA, Agger S, McNeil JA, Lawrence JB, Calendar A, Lenoir G, Thorley-Lawson DA. When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol. 1991 Mar; 65(3):1245-54. PMID: 1847452; PMCID: PMC239896.
      View in: PubMed
      View in: PubMed Central
    73. Moorthy R, Thorley-Lawson DA. Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP. J Virol. 1990 Feb; 64(2):829-37. PMID: 2153246; PMCID: PMC249178.
      View in: PubMed
      View in: PubMed Central
    74. Matsui Y, Shibano K, Kashiwagi H, Yamakawa-Kobayashi K, Inoko H, Staunton DE, Thorley-Lawson DA. Characterization of genomic polymorphism of an activation-associated antigen, Blast-1. Immunogenetics. 1990; 31(3):188-90. PMID: 1969384.
      View in: PubMed
    75. Hurley EA, McNeil JA, Lawrence JB, Thorley-Lawson DA. Genomic integration as a novel mechanism of EBV persistence. Curr Top Microbiol Immunol. 1990; 166:367-74. PMID: 1963586.
      View in: PubMed
    76. Staunton DE, Fisher RC, LeBeau MM, Lawrence JB, Barton DE, Francke U, Dustin M, Thorley-Lawson DA. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23. J Exp Med. 1989 Mar 1; 169(3):1087-99. PMID: 2466936; PMCID: PMC2189294.
      View in: PubMed
      View in: PubMed Central
    77. Thorley-Lawson DA. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim Biophys Acta. 1989 Feb; 948(3):263-86. PMID: 2537659.
      View in: PubMed
    78. Hurley EA, Thorley-Lawson DA. B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med. 1988 Dec 1; 168(6):2059-75. PMID: 2848918; PMCID: PMC2189139.
      View in: PubMed
      View in: PubMed Central
    79. Thorley-Lawson DA. Basic virological aspects of Epstein-Barr virus infection. Semin Hematol. 1988 Jul; 25(3):247-60. PMID: 2841765.
      View in: PubMed
    80. Swendeman SL, Thorley-Lawson D. Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation. Curr Top Microbiol Immunol. 1988; 141:157-64. PMID: 2975205.
      View in: PubMed
    81. Staunton DE, Thorley-Lawson DA. Molecular cloning of the lymphocyte activation marker Blast-1. EMBO J. 1987 Dec 1; 6(12):3695-701. PMID: 2828034; PMCID: PMC553839.
      View in: PubMed
      View in: PubMed Central
    82. Thorley-Lawson DA, Israelsohn ES. Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5384-8. PMID: 3037547; PMCID: PMC298860.
      View in: PubMed
      View in: PubMed Central
    83. Mann KP, Thorley-Lawson D. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J Virol. 1987 Jul; 61(7):2100-8. PMID: 3035211; PMCID: PMC254230.
      View in: PubMed
      View in: PubMed Central
    84. Swendeman S, Thorley-Lawson DA. The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells. EMBO J. 1987 Jun; 6(6):1637-42. PMID: 3038527; PMCID: PMC553536.
      View in: PubMed
      View in: PubMed Central
    85. Edson CM, Farthing MJ, Thorley-Lawson DA, Keusch GT. An 88,000-Mr Giardia lamblia surface protein which is immunogenic in humans. Infect Immun. 1986 Dec; 54(3):621-5. PMID: 3536744; PMCID: PMC260214.
      View in: PubMed
      View in: PubMed Central
    86. Thorley-Lawson DA, Swendeman SL, Edson CM. Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens. J Immunol. 1986 Mar 1; 136(5):1745-51. PMID: 3081632.
      View in: PubMed
    87. Edson CM, Hosler BA, Respess RA, Waters DJ, Thorley-Lawson DA. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein. J Virol. 1985 Oct; 56(1):333-6. PMID: 2993665; PMCID: PMC252547.
      View in: PubMed
      View in: PubMed Central
    88. Mann KP, Staunton D, Thorley-Lawson DA. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J Virol. 1985 Sep; 55(3):710-20. PMID: 2991591; PMCID: PMC255052.
      View in: PubMed
      View in: PubMed Central
    89. Edson CM, Hosler BA, Poodry CA, Schooley RT, Waters DJ, Thorley-Lawson DA. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology. 1985 Aug; 145(1):62-71. PMID: 2990103.
      View in: PubMed
    90. Thorley-Lawson DA, Mann KP. Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med. 1985 Jul 1; 162(1):45-59. PMID: 2989413; PMCID: PMC2187697.
      View in: PubMed
      View in: PubMed Central
    91. Beisel C, Tanner J, Matsuo T, Thorley-Lawson D, Kezdy F, Kieff E. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J Virol. 1985 Jun; 54(3):665-74. PMID: 2987520; PMCID: PMC254850.
      View in: PubMed
      View in: PubMed Central
    92. Thorley-Lawson DA, Nadler LM, Bhan AK, Schooley RT. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol. 1985 May; 134(5):3007-12. PMID: 2984280.
      View in: PubMed
    93. Donohue-Rolfe A, Keusch GT, Edson C, Thorley-Lawson D, Jacewicz M. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med. 1984 Dec 1; 160(6):1767-81. PMID: 6392471; PMCID: PMC2187538.
      View in: PubMed
      View in: PubMed Central
    94. Letvin NL, Aldrich WR, Thorley-Lawson DA, Schlossman SF, Nadler LM. Surface antigen changes during B-lymphocyte activation in primates. Cell Immunol. 1984 Mar; 84(1):163-70. PMID: 6607777.
      View in: PubMed
    95. Hummel M, Thorley-Lawson D, Kieff E. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). J Virol. 1984 Feb; 49(2):413-7. PMID: 6319741; PMCID: PMC255481.
      View in: PubMed
      View in: PubMed Central
    96. Slovin SF, Schooley RT, Thorley-Lawson DA. Analysis of cellular immune response to EBV by using cloned T cell lines. J Immunol. 1983 May; 130(5):2127-32. PMID: 6187840.
      View in: PubMed
    97. Edson CM, Thorley-Lawson DA. Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus. J Virol. 1983 May; 46(2):547-56. PMID: 6302318; PMCID: PMC255157.
      View in: PubMed
      View in: PubMed Central
    98. Thorley-Lawson DA, Schooley RT, Bhan AK, Nadler LM. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell. 1982 Sep; 30(2):415-25. PMID: 6291768.
      View in: PubMed
    99. Thorley-Lawson DA, Poodry CA. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol. 1982 Aug; 43(2):730-6. PMID: 6287039; PMCID: PMC256176.
      View in: PubMed
      View in: PubMed Central
    100. Huber BT, Hansen TH, Skelly RR, Thorley-Lawson DA. Ia.W39 expression correlates with a specific Ir function. J Immunol. 1982 May; 128(5):2349-52. PMID: 6174629.
      View in: PubMed
    101. Thorley-Lawson DA, Edson CM, Geilinger K. Epstein-Barr virus antigens-a challenge to modern biochemistry. Adv Cancer Res. 1982; 36:295-348. PMID: 6289637.
      View in: PubMed
    102. Huber BT, Jones PP, Thorley-Lawson D. Structural analysis of a new B-cell-differentiation antigen associated with products of the I-A subregion of the H-2 complex. Proc Natl Acad Sci U S A. 1981 Jul; 78(7):4525-9. PMID: 6794033; PMCID: PMC319824.
      View in: PubMed
      View in: PubMed Central
    103. Edson CM, Thorley-Lawson DA. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences. J Virol. 1981 Jul; 39(1):172-84. PMID: 6268807; PMCID: PMC171276.
      View in: PubMed
      View in: PubMed Central
    104. Thorley-Lawson DA. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon. J Immunol. 1981 Mar; 126(3):829-33. PMID: 6161964.
      View in: PubMed
    105. Thorley-Lawson DA, Geilinger K. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5307-11. PMID: 6254073; PMCID: PMC350047.
      View in: PubMed
      View in: PubMed Central
    106. Thorley-Lawson DA. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell. J Immunol. 1980 Feb; 124(2):745-51. PMID: 6243331.
      View in: PubMed
    107. Thorley-Lawson DA, Green NM. Reaction of 1-fluoro-2,4-dinitrobenzene and 2,4,6-trinitrobenzenesulphonic acid with membranes of sarcoplasmic reticulum. Biochem J. 1980 Jan 1; 185(1):223-6. PMID: 6445730; PMCID: PMC1161288.
      View in: PubMed
      View in: PubMed Central
    108. Thorley-Lawson DA, Edson CM. Polypeptides of the Epstein-Barr virus membrane antigen complex. J Virol. 1979 Nov; 32(2):458-67. PMID: 228070; PMCID: PMC353577.
      View in: PubMed
      View in: PubMed Central
    109. Thorley-Lawson DA. A virus-free immunogen effective against Epstein-Barr virus. Nature. 1979 Oct 11; 281(5731):486-8. PMID: 226890.
      View in: PubMed
    110. Thorley-Lawson DA. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells. Cell. 1979 Jan; 16(1):33-42. PMID: 217544.
      View in: PubMed
    111. Thorley-Lawson DA, Strominger JL. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus. Virology. 1978 May 15; 86(2):423-31. PMID: 208257.
      View in: PubMed
    112. Purtilo DT, Szymanski I, Bhawan J, Yang JP, Hutt LM, Boto W, DeNicola L, Maier R, Thorley-Lawson D. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet. 1978 Apr 15; 1(8068):798-801. PMID: 85816.
      View in: PubMed
    113. Thorley-Lawson DA, Chess L, Strominger JL. Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T-lymphocytes. IARC Sci Publ. 1978; (24 Pt 2):623-6. PMID: 221386.
      View in: PubMed
    114. Thorley-Lawson DA, Green NM. The reactivity of the thiol groups of the adenosine triphosphatase of sarcoplasmic reticulum and their location on tryptic fragments of the molecule. Biochem J. 1977 Dec 1; 167(3):739-48. PMID: 146488; PMCID: PMC1183722.
      View in: PubMed
      View in: PubMed Central
    115. Thorley-Lawson DA, Chess L, Strominger JL. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med. 1977 Aug 1; 146(2):495-508. PMID: 195004; PMCID: PMC2180764.
      View in: PubMed
      View in: PubMed Central
    116. Thorley-Lawson D, Strominger JL. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid. Nature. 1976 Sep 23; 263(5575):332-4. PMID: 183149.
      View in: PubMed
    117. Nyormoi O, Thorley-Lawson DA, Elkington J, Strominger JL. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proc Natl Acad Sci U S A. 1976 May; 73(5):1745-8. PMID: 179098; PMCID: PMC430377.
      View in: PubMed
      View in: PubMed Central
    118. Thorley-Lawson DA, Green NM. Separation and characterisation of tryptic fragments from the adenosine triphosphatase of sarcoplasmic reticulum. Eur J Biochem. 1975 Nov 1; 59(1):193-200. PMID: 128451.
      View in: PubMed
    119. Green NM, Hardwicke PM, Thorley-Lawson DA. Preliminary studies on the structure of the calcium-activated adenosine triphosphatase of sarcoplasmic reticulum. Biochem Soc Symp. 1974; (39):111-3. PMID: 4283508.
      View in: PubMed
    120. Thorley-Lawson DA, Green NM. Studies on the location and orientation of proteins in the sarcoplasmic reticulum. Eur J Biochem. 1973 Dec 17; 40(2):403-13. PMID: 4131254.
      View in: PubMed
    Thorley-Lawson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _
    This website was supported by the National Center for Research Resources Award Number UL1RR025752 and the National Center for Advancing Translational Sciences, National Institutes of Health, Award Numbers UL1TR000073 and UL1TR001064. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

    Disclaimer | Tufts University | Tufts CTSI 2015